Clinical Trial Update: Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil

View source ↗

Summary

An observational study sponsored by AstraZeneca in Brazil will assess the prevalence and risk factors of hyperkalemia among patients and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Snippet

Sponsor: AstraZeneca | Conditions: Hyperkalemia | Status: RECRUITING